ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted July 14, 2022

FDA Warns Seller of Unauthorized COVID-19 Tests

On June 30, 2022, the FDA issued a warning letter to W.H.P.M, Inc. for distributing COVID antigen tests without approval, clearance, or authorization from the FDA while claiming to mitigate, prevent, treat, diagnose, or cure COVID-19 in people. The agency also found these products to be misbranded because the company did not notify the agency of its intent to introduce the device into commercial distribution.

The unauthorized tests distributed by W.H.P.M include:

  • First Sign COVID 19 Surveillance Test kit
  • First Sign SARS-CoV-2 Antigen Test Packs (bulk products)
  • COVISURE SARS-CoV-2 Antigen Test Kits

In addition, the agency found the test kits to be adulterated because methods used in the facilities are not in conformity with Current Good Manufacturing Practice (cGMP). The company also failed to maintain procedures to document product labeling as well as training records of staff.

The FDA instructed the company to send an email to COVID-19-Task-Force-CDRH@fda.hhs.gov within 48 hours of receipt of the warning, describing the specific steps taken to correct misbranding violations. W.H.P.M, Inc must respond to and take action to correct any cGMP or Quality Systems violations within fifteen business days.

The unauthorized tests have been added to the FDA’s list of Fraudulent Coronavirus Disease Products.

See ConsumerLab’s review of at-home rapid antigen tests, including its Top Picks among these tests.

For more information, use the link below.

W.H.P.M, Inc

See related recalls and warnings:

FDA Warns 5 Sellers of Unapproved COVID-19 Tests

FDA Warns Consumers Not to Use LuSys Laboratories COVID Tests Due to False Results

FDA Warns Sellers of Unapproved COVID-19 Tests, CBD Products

FDA Warns Consumers about Fraudulent Tests, Vaccines, and Treatments for COVID-19

COVID Antibody and Antigen Tests That May Give False Results Recalled